
The biotech startup reduced the time needed to diagnose infections from days to hours with Oracle Autonomous AI Database with AI Vector Search.
Brazil | Life Sciences
“The Oracle AI solution and the product that we developed based on it allowed us to cut at least 50% of costs with almost 100% better performance. And, for us, speed—reducing the time it takes to have test results—is very important.”
Video: Biofy Advances Antibiotic Resistance Research with Oracle Cloud (3:08)
Biofy Technologies is a Brazilian health tech company on a mission to save lives by tackling bacterial infections with precision and speed. Traditional identification and antibiotic resistance testing takes up to five days; Biofy’s platform, powered by AI and DNA sequencing, delivers answers in just four hours. The company chose Oracle Autonomous AI Database with AI Vector Search for secure storage, high performance, and seamless analysis of 90TB of DNA data, both real and synthetic. The Oracle AI data platform in combination with Oracle Cloud Infrastructure (OCI) Generative AI enables rapid, millisecond-level searches across vast, evolving genomic data sets—helping clinicians deliver the right antibiotic sooner. Since implementation, Biofy has cut costs by 50% and doubled performance. In partner hospitals, rapid diagnostics have reduced bacterial infection death rates from around 70% to 50%, making a tangible difference for patients and their families.